August 01, 2014 8:04 PM ET

Biotechnology

Company Overview of BEAT BioTherapeutics Corp.

Company Overview

BEAT BioTherapeutics Corp., a biotechnology company, develops therapies for the treatment of heart diseases. The company focuses on developing a gene therapy to improve cardiac performance in the setting of heart failure. Its gene therapy represents a transformational technology for the treatment of heart failure and myocardial infarctions. The company was founded in 2008 and is based in Bellevue, Washington.

1380-112th Avenue NE

Suite 200

Bellevue, WA 98004

United States

Founded in 2008

Phone:

425-269-3478

Key Executives for BEAT BioTherapeutics Corp.

Chief Executive Officer and Director
Age: 60
President
Scientific Co-Founder and Chairman of Cientific Advisory Board
Ccientific Co-Founder and Scientific Advisory Board Member
Scientific Co-Founder and Scientific Advisory Board Member
Compensation as of Fiscal Year 2014.

BEAT BioTherapeutics Corp. Key Developments

BEAT BioTherapeutics Corp. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-20-2014 10:30 AM

BEAT BioTherapeutics Corp. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-20-2014 10:30 AM. Venue: Washington State Convention Center, Seattle, Washington, United States.

BEAT BioTherapeutics Corp. Appoints Sam L. Teichman as Chief Medical Officer and Director

BEAT BioTherapeutics Corp. announced the appointment of Sam L. Teichman, MD, FACC, FESC, FACP, as Chief Medical Officer and Director. Dr. Teichman has nearly 30 years of global clinical research and drug development leadership experience across broad therapeutic areas with a focus on cardiovascular disease and heart failure. As Senior Vice President of R&D and CMO at Corthera, he led the medical effort to develop serelaxin for the treatment of acute heart failure.

BEAT BioTherapeutics Corp. Presents at The 7th Annual OneMedForum San Francisco 2014 Conference, Jan-13-2014

BEAT BioTherapeutics Corp. Presents at The 7th Annual OneMedForum San Francisco 2014 Conference, Jan-13-2014 . Venue: Westin San Francisco Market Street, San Francisco, California, United States.

Similar Private Companies By Industry

Company Name Region
Genome Corp. United States
Human Genome Sciences Inc. United States
Grant Life Sciences, Inc. United States
Wellstat Biologics Corporation United States
Quantapore Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BEAT BioTherapeutics Corp., please visit www.beatbiotherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.